SCHEMBL12114841

SCHEMBL12114841

CC1(C)c2ccccc2-c2ccc(-c3cc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc(-c4nc5ccccc5n4-c4ccccc4)c3)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.41
ESR2 Q92731 3/20 0.41
RECQL P46063 1/20 0.39
PTGER4 P35408 1/20 0.39
GRIA1 P42261 1/20 0.39
CACNG8 Q8WXS5 1/20 0.39
CACNG2 Q9Y698 1/20 0.39
HTT P42858 2/20 0.38
MAPK1 P28482 1/20 0.38
HDAC1 Q13547 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
PTGS2 P35354 1/20 0.36
ALDH1A1 P00352 6/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ATR Q13535 1/20 0.35
MEN1 O00255 1/20 0.35
HSP90AA1 P07900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8736348 0.96 RECQL (0.39) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL12114844 0.95 RECQL (0.39) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL12114842 0.94 ESR1 (0.40) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL24570626 0.91 ESR1 (0.45) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL12114843 0.90 ESR1 (0.43) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL24570233 0.90 ESR1 (0.50) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL24570824 0.90 ESR1 (0.47) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL14769556 0.88 ESR1 (0.41) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL19194421 0.88 ESR1 (0.39) ESR1ESR2RECQLPTGER4GRIA1
SCHEMBL2603508 0.87 ESR1 (0.45) ESR1ESR2RECQLPTGER4GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9530970-B2 Benzimidazole compound, organic photoelectric device including the same, and display element including the same CHEIL INDUSTRIES, INC. (KR) 2016-12-27 US disclosed
US-9530970-B2 Benzimidazole compound, organic photoelectric device including the same, and display element including the same CHEIL INDUSTRIES, INC. (KR) 2016-12-27 US disclosed
US-20130256641-A1 BENZIMIDAZOLE COMPOUND, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY ELEMENT INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2013-10-03 US disclosed
US-20130256641-A1 BENZIMIDAZOLE COMPOUND, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY ELEMENT INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2013-10-03 US disclosed
US-20110272676-A1 BENZIMIDAZOLE COMPOUND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY ELEMENT INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2011-11-10 US disclosed
US-20110272676-A1 BENZIMIDAZOLE COMPOUND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY ELEMENT INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110272676-A1 BENZIMIDAZOLE COMPOUND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY ELEMENT INCLUDING THE SAME CYP2C19, BMI1, CDKN1A ESR1 459/4885ESR2 2990/4885RECQL 1743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.